The Director-General of the UN World Health Organization (WHO) has called on drug manufacturer Pfizer to do more to ensure that its new COVID-19 oral antiviral medication is available quickly, to provide effective treatment to countries that may struggle to afford it.
WHO scales up Ebola readiness in 22 countries across three continents 
Ukraine: Civilian casualty rates among ‘deadliest’ in years, as energy attacks intensify 
As disasters mount, next UN climate summit faces a test of trust 
Gaza: 340 children killed despite ceasefire agreement – UNICEF 
Security Council LIVE: Sudan’s war spreads as drones and hunger take a deadly toll 
Guterres urges faster action and financing to stop biodiversity loss